Therapeutic Cell Production Selected Publications

  • Birkhäuser F.D., Koya R.C., Neufeld C., Rampersaud E.N., Lu X., Micewicz E.D., Chodon T., Atefi M., Kroeger N., Chandramouli G.V., Li G., Said J.W., McBride W.H., Kabbinavar F.F., Ribas A., Pantuck A.J., Belldegrun A.S., Riss J. Dendritic Cell-Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM·CAIX in Immunocompetent Mouse Models. J Immunother. 2013 Jan 30.
  • Candotti F, Shaw KL, Muul L, Carbonaro D, Sokolic R, Choi C, Shepherd S, Garabedian E, Kesserwan C, Jagadeesh G, Dunbar CE, Tisdale JF, Weinberg KI, Crooks GM, Kapoor N, Shah A, Abdel-Azim H, Yu X, Smogorzewska M, Wayne AS, Roswenblatt HM, Davis CM, Hanson C, Rishi RG, Wang X, Gjertson D, Fu P, Yange OO, Balamurugan A, Bauer G, Engel BC, Podsakoff GM, Hershfield M, Blaese RM, Parkman R, and Kohn DB. (2012) Gene Thearpy for Adenosine Deaminase-deficient server combined immune Deficiency: Clinical Comparison of Retrovial Vectors and Treatment Plans. Blood Volume 120, no. 18, pgs. 3635-3646.
  • Tumeh PC, Koya RC, Chodon T, Graham NA, Graeber TG, Comin-Anduix B, Ribas A. The impact of Ex Vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy. Journal of Immunotherapy. 2010 Oct. 33(8), 759-768.
  • Koya RC*, Tumeh PC*, Chodon T, Graham NA, Graeber TG, Comin-Anduix B, Ribas A. The impact of ex vivo clinical grade activation protocols on human T cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy. J Immunoherapy, 2010 Oct; 33(8):759-68.
  • Kahl CA, Tarantal AF, Lee CI, Jimenez DF, Choi C, Pepper K, Petersen D, Fletcher MD, Leapley AC, Fisher J, Burns TS, Ultsch MN, Dorey FJ, Kohn DB. (2006) Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vector. Exp Hematol. Volume 34, Issue 3, pgs. 369-81
  • Podsakoff GM, Engel BC, Carbonaro DA, Choi C, Smogorzewska EM, Bauer G, Selander D, Csik S, Wilson K, Betts MR, Koup RA, Nabel GJ, Bishop K, King S, Schmidt M, von Kalle C, Church JA, Kohn DB. (2005) Selective survival of peripheral blood lymphocytes in children with HIV-1 following delivery of an anti-HIV gene to bone marrow CD34(+) cells. Mol Therapy Volume 12, Issue 1, pgs. 77-86